Global Sexual Dysfunction Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sexual Dysfunction Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Sexual Dysfunction Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Sexual Dysfunction Drugs by Country/Region, 2017, 2022 & 2028

2.2 Sexual Dysfunction Drugs Segment by Type

2.2.1 Oral Therapy

2.2.2 Intracavernosal Therapy

2.2.3 Hormonal Therapy

2.2.4 Transurethral Therapy

2.3 Sexual Dysfunction Drugs Sales by Type

2.3.1 Global Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Sexual Dysfunction Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Sexual Dysfunction Drugs Sale Price by Type (2017-2022)

2.4 Sexual Dysfunction Drugs Segment by User

2.4.1 Male

2.4.2 Female

2.5 Sexual Dysfunction Drugs Sales by User

2.5.1 Global Sexual Dysfunction Drugs Sale Market Share by User (2017-2022)

2.5.2 Global Sexual Dysfunction Drugs Revenue and Market Share by User (2017-2022)

2.5.3 Global Sexual Dysfunction Drugs Sale Price by User (2017-2022)

3 Global Sexual Dysfunction Drugs by Company

3.1 Global Sexual Dysfunction Drugs Breakdown Data by Company

3.1.1 Global Sexual Dysfunction Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Sexual Dysfunction Drugs Sales Market Share by Company (2020-2022)

3.2 Global Sexual Dysfunction Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Sexual Dysfunction Drugs Revenue by Company (2020-2022)

3.2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Sexual Dysfunction Drugs Sale Price by Company

3.4 Key Manufacturers Sexual Dysfunction Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Sexual Dysfunction Drugs Product Location Distribution

3.4.2 Players Sexual Dysfunction Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sexual Dysfunction Drugs by Geographic Region

4.1 World Historic Sexual Dysfunction Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Sexual Dysfunction Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Sexual Dysfunction Drugs Annual Revenue by Geographic Region

4.2 World Historic Sexual Dysfunction Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Sexual Dysfunction Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Sexual Dysfunction Drugs Annual Revenue by Country/Region

4.3 Americas Sexual Dysfunction Drugs Sales Growth

4.4 APAC Sexual Dysfunction Drugs Sales Growth

4.5 Europe Sexual Dysfunction Drugs Sales Growth

4.6 Middle East & Africa Sexual Dysfunction Drugs Sales Growth

5 Americas

5.1 Americas Sexual Dysfunction Drugs Sales by Country

5.1.1 Americas Sexual Dysfunction Drugs Sales by Country (2017-2022)

5.1.2 Americas Sexual Dysfunction Drugs Revenue by Country (2017-2022)

5.2 Americas Sexual Dysfunction Drugs Sales by Type

5.3 Americas Sexual Dysfunction Drugs Sales by User

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sexual Dysfunction Drugs Sales by Region

6.1.1 APAC Sexual Dysfunction Drugs Sales by Region (2017-2022)

6.1.2 APAC Sexual Dysfunction Drugs Revenue by Region (2017-2022)

6.2 APAC Sexual Dysfunction Drugs Sales by Type

6.3 APAC Sexual Dysfunction Drugs Sales by User

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Sexual Dysfunction Drugs by Country

7.1.1 Europe Sexual Dysfunction Drugs Sales by Country (2017-2022)

7.1.2 Europe Sexual Dysfunction Drugs Revenue by Country (2017-2022)

7.2 Europe Sexual Dysfunction Drugs Sales by Type

7.3 Europe Sexual Dysfunction Drugs Sales by User

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sexual Dysfunction Drugs by Country

8.1.1 Middle East & Africa Sexual Dysfunction Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Sexual Dysfunction Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Sexual Dysfunction Drugs Sales by Type

8.3 Middle East & Africa Sexual Dysfunction Drugs Sales by User

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Sexual Dysfunction Drugs

10.3 Manufacturing Process Analysis of Sexual Dysfunction Drugs

10.4 Industry Chain Structure of Sexual Dysfunction Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Sexual Dysfunction Drugs Distributors

11.3 Sexual Dysfunction Drugs Customer

12 World Forecast Review for Sexual Dysfunction Drugs by Geographic Region

12.1 Global Sexual Dysfunction Drugs Market Size Forecast by Region

12.1.1 Global Sexual Dysfunction Drugs Forecast by Region (2023-2028)

12.1.2 Global Sexual Dysfunction Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Sexual Dysfunction Drugs Forecast by Type

12.7 Global Sexual Dysfunction Drugs Forecast by User

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Sexual Dysfunction Drugs Product Offered

13.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Sexual Dysfunction Drugs Product Offered

13.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Sexual Dysfunction Drugs Product Offered

13.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Eli Lilly

13.4.1 Eli Lilly Company Information

13.4.2 Eli Lilly Sexual Dysfunction Drugs Product Offered

13.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eli Lilly Main Business Overview

13.4.5 Eli Lilly Latest Developments

13.5 AbbVie

13.5.1 AbbVie Company Information

13.5.2 AbbVie Sexual Dysfunction Drugs Product Offered

13.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AbbVie Main Business Overview

13.5.5 AbbVie Latest Developments

13.6 Bayer

13.6.1 Bayer Company Information

13.6.2 Bayer Sexual Dysfunction Drugs Product Offered

13.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bayer Main Business Overview

13.6.5 Bayer Latest Developments

13.7 Teva Pharmaceutical Industries

13.7.1 Teva Pharmaceutical Industries Company Information

13.7.2 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Offered

13.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Teva Pharmaceutical Industries Main Business Overview

13.7.5 Teva Pharmaceutical Industries Latest Developments

13.8 Takeda

13.8.1 Takeda Company Information

13.8.2 Takeda Sexual Dysfunction Drugs Product Offered

13.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Takeda Main Business Overview

13.8.5 Takeda Latest Developments

13.9 Apricus Biosciences

13.9.1 Apricus Biosciences Company Information

13.9.2 Apricus Biosciences Sexual Dysfunction Drugs Product Offered

13.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Apricus Biosciences Main Business Overview

13.9.5 Apricus Biosciences Latest Developments

13.10 Emotional Brain

13.10.1 Emotional Brain Company Information

13.10.2 Emotional Brain Sexual Dysfunction Drugs Product Offered

13.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Emotional Brain Main Business Overview

13.10.5 Emotional Brain Latest Developments

13.11 Ivix LLX

13.11.1 Ivix LLX Company Information

13.11.2 Ivix LLX Sexual Dysfunction Drugs Product Offered

13.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ivix LLX Main Business Overview

13.11.5 Ivix LLX Latest Developments

13.12 Leadiant Biosciences

13.12.1 Leadiant Biosciences Company Information

13.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Product Offered

13.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Leadiant Biosciences Main Business Overview

13.12.5 Leadiant Biosciences Latest Developments

13.13 NexMed

13.13.1 NexMed Company Information

13.13.2 NexMed Sexual Dysfunction Drugs Product Offered

13.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 NexMed Main Business Overview

13.13.5 NexMed Latest Developments

13.14 S1 Biopharma

13.14.1 S1 Biopharma Company Information

13.14.2 S1 Biopharma Sexual Dysfunction Drugs Product Offered

13.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 S1 Biopharma Main Business Overview

13.14.5 S1 Biopharma Latest Developments

13.15 Vietstar Biomedical Research

13.15.1 Vietstar Biomedical Research Company Information

13.15.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Offered

13.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Vietstar Biomedical Research Main Business Overview

13.15.5 Vietstar Biomedical Research Latest Developments

14 Research Findings and Conclusion

Table 1. Sexual Dysfunction Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Sexual Dysfunction Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Therapy

Table 4. Major Players of Intracavernosal Therapy

Table 5. Major Players of Hormonal Therapy

Table 6. Major Players of Transurethral Therapy

Table 7. Global Sexual Dysfunction Drugs Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Sexual Dysfunction Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Sexual Dysfunction Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Sexual Dysfunction Drugs Sales by User (2017-2022) & (K Pcs)

Table 13. Global Sexual Dysfunction Drugs Sales Market Share by User (2017-2022)

Table 14. Global Sexual Dysfunction Drugs Revenue by User (2017-2022)

Table 15. Global Sexual Dysfunction Drugs Revenue Market Share by User (2017-2022)

Table 16. Global Sexual Dysfunction Drugs Sale Price by User (2017-2022) & (USD/Pcs)

Table 17. Global Sexual Dysfunction Drugs Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Sexual Dysfunction Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Sexual Dysfunction Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Sexual Dysfunction Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Sexual Dysfunction Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Sexual Dysfunction Drugs Producing Area Distribution and Sales Area

Table 23. Players Sexual Dysfunction Drugs Products Offered

Table 24. Sexual Dysfunction Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Sexual Dysfunction Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Sexual Dysfunction Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Sexual Dysfunction Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Sexual Dysfunction Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Sexual Dysfunction Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Sexual Dysfunction Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Sexual Dysfunction Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Sexual Dysfunction Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Sexual Dysfunction Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Sexual Dysfunction Drugs Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Sexual Dysfunction Drugs Sales by User (2017-2022) & (K Pcs)

Table 42. Americas Sexual Dysfunction Drugs Sales Market Share by User (2017-2022)

Table 43. APAC Sexual Dysfunction Drugs Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Sexual Dysfunction Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Sexual Dysfunction Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Sexual Dysfunction Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Sexual Dysfunction Drugs Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Sexual Dysfunction Drugs Sales by User (2017-2022) & (K Pcs)

Table 50. APAC Sexual Dysfunction Drugs Sales Market Share by User (2017-2022)

Table 51. Europe Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Sexual Dysfunction Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Sexual Dysfunction Drugs Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Sexual Dysfunction Drugs Sales by User (2017-2022) & (K Pcs)

Table 58. Europe Sexual Dysfunction Drugs Sales Market Share by User (2017-2022)

Table 59. Middle East & Africa Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Sexual Dysfunction Drugs Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Sexual Dysfunction Drugs Sales by User (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by User (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Sexual Dysfunction Drugs

Table 68. Key Market Challenges & Risks of Sexual Dysfunction Drugs

Table 69. Key Industry Trends of Sexual Dysfunction Drugs

Table 70. Sexual Dysfunction Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Sexual Dysfunction Drugs Distributors List

Table 73. Sexual Dysfunction Drugs Customer List

Table 74. Global Sexual Dysfunction Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Sexual Dysfunction Drugs Sales Market Forecast by Region

Table 76. Global Sexual Dysfunction Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Sexual Dysfunction Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Sexual Dysfunction Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Sexual Dysfunction Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Sexual Dysfunction Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Sexual Dysfunction Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Sexual Dysfunction Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Sexual Dysfunction Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Sexual Dysfunction Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Sexual Dysfunction Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Sexual Dysfunction Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Sexual Dysfunction Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Sexual Dysfunction Drugs Sales Forecast by User (2023-2028) & (K Pcs)

Table 91. Global Sexual Dysfunction Drugs Sales Market Share Forecast by User (2023-2028)

Table 92. Global Sexual Dysfunction Drugs Revenue Forecast by User (2023-2028) & ($ Millions)

Table 93. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by User (2023-2028)

Table 94. Pfizer Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer Sexual Dysfunction Drugs Product Offered

Table 96. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. GlaxoSmithKline Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. GlaxoSmithKline Sexual Dysfunction Drugs Product Offered

Table 101. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. GlaxoSmithKline Main Business

Table 103. GlaxoSmithKline Latest Developments

Table 104. Merck Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Sexual Dysfunction Drugs Product Offered

Table 106. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Eli Lilly Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Eli Lilly Sexual Dysfunction Drugs Product Offered

Table 111. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Eli Lilly Main Business

Table 113. Eli Lilly Latest Developments

Table 114. AbbVie Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. AbbVie Sexual Dysfunction Drugs Product Offered

Table 116. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. AbbVie Main Business

Table 118. AbbVie Latest Developments

Table 119. Bayer Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Bayer Sexual Dysfunction Drugs Product Offered

Table 121. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Bayer Main Business

Table 123. Bayer Latest Developments

Table 124. Teva Pharmaceutical Industries Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Offered

Table 126. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Teva Pharmaceutical Industries Main Business

Table 128. Teva Pharmaceutical Industries Latest Developments

Table 129. Takeda Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Takeda Sexual Dysfunction Drugs Product Offered

Table 131. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. Takeda Main Business

Table 133. Takeda Latest Developments

Table 134. Apricus Biosciences Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Apricus Biosciences Sexual Dysfunction Drugs Product Offered

Table 136. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Apricus Biosciences Main Business

Table 138. Apricus Biosciences Latest Developments

Table 139. Emotional Brain Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Emotional Brain Sexual Dysfunction Drugs Product Offered

Table 141. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Emotional Brain Main Business

Table 143. Emotional Brain Latest Developments

Table 144. Ivix LLX Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Ivix LLX Sexual Dysfunction Drugs Product Offered

Table 146. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Ivix LLX Main Business

Table 148. Ivix LLX Latest Developments

Table 149. Leadiant Biosciences Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Leadiant Biosciences Sexual Dysfunction Drugs Product Offered

Table 151. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Leadiant Biosciences Main Business

Table 153. Leadiant Biosciences Latest Developments

Table 154. NexMed Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. NexMed Sexual Dysfunction Drugs Product Offered

Table 156. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. NexMed Main Business

Table 158. NexMed Latest Developments

Table 159. S1 Biopharma Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. S1 Biopharma Sexual Dysfunction Drugs Product Offered

Table 161. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 162. S1 Biopharma Main Business

Table 163. S1 Biopharma Latest Developments

Table 164. Vietstar Biomedical Research Basic Information, Sexual Dysfunction Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Offered

Table 166. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 167. Vietstar Biomedical Research Main Business

Table 168. Vietstar Biomedical Research Latest Developments

List of Figures

Figure 1. Picture of Sexual Dysfunction Drugs

Figure 2. Sexual Dysfunction Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Sexual Dysfunction Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Sexual Dysfunction Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Sexual Dysfunction Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Therapy

Figure 10. Product Picture of Intracavernosal Therapy

Figure 11. Product Picture of Hormonal Therapy

Figure 12. Product Picture of Transurethral Therapy

Figure 13. Global Sexual Dysfunction Drugs Sales Market Share by Type in 2021

Figure 14. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Sexual Dysfunction Drugs Consumed in Male

Figure 16. Global Sexual Dysfunction Drugs Market: Male (2017-2022) & (K Pcs)

Figure 17. Sexual Dysfunction Drugs Consumed in Female

Figure 18. Global Sexual Dysfunction Drugs Market: Female (2017-2022) & (K Pcs)

Figure 19. Global Sexual Dysfunction Drugs Sales Market Share by User (2017-2022)

Figure 20. Global Sexual Dysfunction Drugs Revenue Market Share by User in 2021

Figure 21. Sexual Dysfunction Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Sexual Dysfunction Drugs Revenue Market Share by Company in 2021

Figure 23. Global Sexual Dysfunction Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Sexual Dysfunction Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Sexual Dysfunction Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Sexual Dysfunction Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Sexual Dysfunction Drugs Sales 2017-2022 (K Pcs)

Figure 28. Americas Sexual Dysfunction Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Sexual Dysfunction Drugs Sales 2017-2022 (K Pcs)

Figure 30. APAC Sexual Dysfunction Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Sexual Dysfunction Drugs Sales 2017-2022 (K Pcs)

Figure 32. Europe Sexual Dysfunction Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Sexual Dysfunction Drugs Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Sexual Dysfunction Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Sexual Dysfunction Drugs Sales Market Share by Country in 2021

Figure 36. Americas Sexual Dysfunction Drugs Revenue Market Share by Country in 2021

Figure 37. United States Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Sexual Dysfunction Drugs Sales Market Share by Region in 2021

Figure 42. APAC Sexual Dysfunction Drugs Revenue Market Share by Regions in 2021

Figure 43. China Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Sexual Dysfunction Drugs Sales Market Share by Country in 2021

Figure 50. Europe Sexual Dysfunction Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Sexual Dysfunction Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Sexual Dysfunction Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Sexual Dysfunction Drugs in 2021

Figure 64. Manufacturing Process Analysis of Sexual Dysfunction Drugs

Figure 65. Industry Chain Structure of Sexual Dysfunction Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles